Transcription factors are potential therapeutic targets in epilepsy

被引:7
|
作者
Sun, Qihan [1 ]
Xu, Wenbo [1 ]
Piao, Jingjing [1 ]
Su, Jingyun [1 ]
Ge, Tongtong [1 ]
Cui, Ranji [1 ]
Yang, Wei [1 ]
Li, Bingjin [1 ]
机构
[1] Second Hosp Jilin Univ, Jilin Prov Key Lab Mol & Chem Genet, Changchun, Peoples R China
基金
中国国家自然科学基金;
关键词
epilepsy; mechanism; transcription factors; RESTRICTIVE SILENCER FACTOR; INDUCED NEURONAL DAMAGE; GENE-EXPRESSION; CONDITIONAL DELETION; MENTAL-RETARDATION; TNF-ALPHA; P53; ARX; SEIZURES; KLF4;
D O I
10.1111/jcmm.17518
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Academics generally believe that imbalance between excitation and inhibition of the nervous system is the root cause of epilepsy. However, the aetiology of epilepsy is complex, and its pathogenesis remains unclear. Many studies have shown that epilepsy is closely related to genetic factors. Additionally, the involvement of a variety of tumour-related transcription factors in the pathogenesis of epilepsy has been confirmed, which also confirms the heredity of epilepsy. In this review, we summarize the existing research on a variety of transcription factors and epilepsy and present relevant evidence related to transcription factors that may be targets in epilepsy. This information is of great significance for revealing the in-depth molecular and cellular mechanisms of epilepsy.
引用
收藏
页码:4875 / 4885
页数:11
相关论文
共 50 条
  • [31] HOX transcription factors are potential targets and markers in malignant mesothelioma
    Richard Morgan
    Guy Simpson
    Sophie Gray
    Cheryl Gillett
    Zsuzsanna Tabi
    James Spicer
    Kevin J. Harrington
    Hardev S. Pandha
    BMC Cancer, 16
  • [32] Transcription Factors as Novel Therapeutic Targets and Drivers of Prostate Cancer Progression
    Xie, Kangzhe
    Tan, Keely
    Naylor, Matthew J.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] HOX TRANSCRIPTION FACTORS ARE POTENTIAL TARGETS AND MARKERS IN MALIGNANT MESOTHELIOMA
    Morgan, Richard
    Gray, Sophie
    Gillett, Cheryl
    Tabi, Zsuzsanna
    Launchbury, Francesca
    Spicer, James
    Harrington, Kevin
    Pandha, Hardev S.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6069 - 6071
  • [34] Transcription factors as targets of novel therapeutic approaches of autoimmune diseases - Preface
    Neeck, G
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (23)
  • [35] Non-histone substrates of histone deacetylases as potential therapeutic targets in epilepsy
    Kumar, Sonali
    Attrish, Diksha
    Srivastava, Arpna
    Banerjee, Jyotirmoy
    Tripathi, Manjari
    Chandra, P. Sarat
    Dixit, Aparna Banerjee
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (01) : 75 - 85
  • [36] circRNA: Regulatory factors and potential therapeutic targets in inflammatory dermatoses
    Liu, Ruifeng
    Zhang, Luyao
    Zhao, Xincheng
    Liu, Jia
    Chang, Wenjuan
    Zhou, Ling
    Zhang, Kaiming
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (16) : 4389 - 4400
  • [37] The Growth Factors: Potential Biomarkers and Therapeutic Targets in Kidney Diseases
    Tang, Wei
    Zhang, Yufeng
    Cui, Sijia
    Yi, Fan
    KIDNEY DISEASES, 2022, 8 (05) : 368 - 380
  • [38] EVALUATION OF HYPOXIA INDUCIBLE FACTORS AS POTENTIAL THERAPEUTIC TARGETS IN EPENDYMOMAS
    Abraham, Shirley
    Jensen, Randy
    Khatua, Soumen
    PEDIATRIC BLOOD & CANCER, 2011, 56 (06) : 960 - 961
  • [39] ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells
    Xavier, Pedro L. P.
    Cordeiro, Yonara G.
    Rochetti, Arina L.
    Sangalli, Juliano R.
    Zuccari, Debora A. P. C.
    Silveira, Juliano C.
    Bressan, Fabiana F.
    Fukumasu, Heidge
    VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (04) : 596 - 605
  • [40] Novel therapeutic targets for epilepsy intervention
    Kambli, Lazari
    Bhatt, Lokesh Kumar
    Oza, Manisha
    Prabhavalkar, Kedar
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2017, 51 : 27 - 34